The Magazine behind NZ’s Export Drive
APL, the container shipping arm of Singapore’s shipping and logistics group Neptune Orient Lines, has announced it will scan export containers for nuclear radiation at its terminal at Yokohama, according to the Shipping Gazette.
APL, the container shipping arm of Singapore’s shipping and logistics group Neptune Orient Lines, has announced it will scan export containers for nuclear radiation at its terminal at Yokohama, according to the Shipping Gazette.
APL, the container shipping arm of Singapore’s shipping and logistics group Neptune Orient Lines, has announced it will scan export containers for nuclear radiation at its terminal at Yokohama, according to the Shipping Gazette.
APL, the container shipping arm of Singapore’s shipping and logistics group Neptune Orient Lines, has announced it will scan export containers for nuclear radiation at its terminal at Yokohama, according to the Shipping Gazette.
APL, the container shipping arm of Singapore’s shipping and logistics group Neptune Orient Lines, has announced it will scan export containers for nuclear radiation at its terminal at Yokohama, according to the Shipping Gazette.
APL, the container shipping arm of Singapore’s shipping and logistics group Neptune Orient Lines, has announced it will scan export containers for nuclear radiation at its terminal at Yokohama, according to the Shipping Gazette....
The fall in vineyard values had increased banks’ “anxiety” about land as security. A large number of companies were on the market, particularly in central Otago and Marlborough, and quite a few were forced...
Auckland-based Living Cell Technologies Limited, a company developing cell implant therapy to treat diabetes, says it has entered into an agreement to raise A$3 million through a placement of shares to Otsuka Pharmaceutical Factory,...
Auckland-based Living Cell Technologies Limited, a company developing cell implant therapy to treat diabetes, says it has entered into an agreement to raise A$3 million through a placement of shares to Otsuka Pharmaceutical Factory,...
Auckland-based Living Cell Technologies Limited, a company developing cell implant therapy to treat diabetes, says it has entered into an agreement to raise A$3 million through a placement of shares to Otsuka Pharmaceutical Factory,...
